Research Interests:
Antiretroviral Therapy, Fungal Infections, Antimicrobial Therapy

Select Publications:

HW Lampiris and AS Lauring. 2005. Clinical approach to antiretroviral salvage therapy. Infectious Diseases Special Edition (in press)

JK Louie and HW Lampiris.; 2004. Infection and travel in patients with HIV disease. In “The AIDS Knowledge Base,” electronic textbook, at: http://hivinsite.ucsf.edu/InSite?page=kb-03&doc=kb-03-01-0

HW Lampiris and DS Maddix. 2004. "Clinical Use of Antimicrobial Agents" in Basic and Clinical Pharmacology, 9th Edition, BG Katzung, editor, McGraw-Hill, New York

PW Hunt, JN Martin, E Sinclair, B Bredt, E Hagos, H Lampiris, SG Deeks. 2003. T Cell Activation is Associated with Lower CD4+ gains in HIV-Infected Patients with Sustained Viral Suppression on Antiretroviral Therapy. J Infect Dis 187:1534-43.

DL Stevens, D. Herr, H. Lampiris, JL Hunt, DH Batts, B Hafkin and the Linezolid MRSA Study Group. 2002. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases 34: 1481-90

RT Schooley, P Ruane, RA Myers, H Lampiris, D Berger, I McGowan, S Chen, MD Miller, E Isaacson, J Elder, A McCullough, A Cheng and the Study 902 Team. 2002. Tenofovir DF in highly antiretroviral-experienced patients: results from a 48 week, randomized, double blind study. AIDS 16:1257-63.

CB Hare, MP Vu, C Grunfeld, H Lampiris. 2002. Simvastatin-nelfinavir interaction leading to rhabdomyolysis and death. Clinical Infectious Diseases 35:e111-112

Education and Training:

B.A., B.S., Brown University, 1981.

M.D., University of California, San Francisco, 1985.

Internal Medicine Residency, McGaw Medical Center of Northwestern University, 1985-1988.

Infectious Disease Fellowship, University of California, San Francisco, 1989 – 1991.